Skip to main content
. 2016 Nov 30;30(12):1165–1180. doi: 10.1177/0269881116675512

Table 1.

Demographic and clinical characteristics of study participants.a

Characteristic Categories Psilocybin first
Niacin first
Total
n=14 n=15 n=29
Sex Female 7 50% 11 73% 18 62%
Male 7 50% 4 27% 11 38%
Age; mean (SD) Range 22–75 52 (15.03) 60.27 (9.45) 56.28 (12.93)
Race White/Caucasian 13 93% 13 87% 26 90%
Black/African American 0 0% 0 0% 0 0%
Hispanic/Latino 0 0% 0 0% 0 0%
Asian 0 0% 0 0% 0 0%
American Indian/Native American 0 0% 0 0% 0 0%
Other 1 7% 2 13% 3 10%
Religious/spiritual beliefs Atheist/agnostic 4 29% 10 67% 14 48%
Jewish 4 29% 1 7% 5 17%
Catholic 2 14% 0 0% 2 7%
Other Christian 3 21% 1 7% 4 14%
Other faith/tradition 1 7% 3 20% 4 14%
Site of cancer Breast 4 29% 5 33% 9 31%
Reproductive 3 21% 5 33% 8 28%
Digestive cancers 3 21% 2 13% 5 17%
Lymphoma/leukemia 2 14% 2 13% 4 14%
Other types 2 14% 1 7% 3 10%
Stage of cancer Stage IV 3 21% 7 47% 10 34%
Stage III 4 29% 4 27% 8 28%
Stage II 1 7% 4 27% 5 17%
Stage I 5 36% 0 0% 5 17%
Other 1 7% 0 0% 1 3%
SCID (DSM-IV) diagnosisb Adjustment disorder w/anxiety and depressed mood, chronic 2 14% 6 40% 8 28%
Adjustment disorder w/anxiety, chronic 10 71% 8 53% 18 62%
Generalized anxiety disorder 2 14% 1 7% 3 10%
Hallucinogen use No 7 50% 6 40% 13 45%
Yes 7 50% 9 60% 16 55%
Employment status Full-time employed 6 43% 5 33% 12 41%
Part-time employed 2 14% 2 13% 4 14%
Full-time student 1 7% 0 0% 1 3%
Unemployed 2 14% 1 7% 2 7%
Self-employed 1 7% 1 7% 2 7%
Retired 0 0% 6 40% 6 21%
Long-term disability 2 14% 0 0% 2 7%
Educational attainment Grade 7–12 w/o graduating high school 1 7% 0 0% 1 3%
Graduated HS or equivalent 0 0% 1 7% 1 3%
Part college 1 7% 3 20% 4 14%
Graduated 4-year college 5 36% 4 27% 9 31%
Completed grad/professional school 7 50% 7 47% 14 48%
Marital status Never married 5 36% 3 20% 8 28%
Widowed 0 0% 2 13% 2 7%
Cohabitation 2 14% 0 0% 2 7%
Divorced 1 7% 3 20% 4 14%
Married 6 43% 7 47% 13 45%
Living arrangements Live with spouse/partner/family 11 79% 9 60% 20 69%
Live alone 2 14% 6 40% 8 28%
Other; lived with roommates 1 7% 0 0% 1 3%
a

The two dose-sequence groups did not significantly differ on any demographic or clinical characteristic measures.

b

Psychiatric classification was based on the structured clinical interview for the DSM-IV (SCID-IV).

Nearly two-thirds (59%) of participants had previously been treated with anti-depressant or anxiolytic medication, but none were on any psychotropics before study enrollment per inclusion/exclusion criteria.